These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36765743)

  • 1. Hepatectomy versus Chemotherapy for Resectable Colorectal Liver Metastases in Progression after Perioperative Chemotherapy: Expanding the Boundaries of the Curative Intent.
    Famularo S; Milana F; Cimino M; Procopio F; Costa G; Galvanin J; Paoluzzi Tomada E; Bunino FM; Palmisano A; Donadon M; Torzilli G
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized Phase II Study of Perioperative Chemotherapy Plus Bevacizumab Versus Postoperative Chemotherapy Plus Bevacizumab in Patients With Upfront Resectable Hepatic Colorectal Metastases.
    Chun YJ; Kim SG; Lee KW; Cho SH; Kim TW; Baek JY; Park YS; Hong S; Chu CW; Beom SH; Jung M; Shin SJ; Ahn JB
    Clin Colorectal Cancer; 2020 Sep; 19(3):e140-e150. PubMed ID: 32402681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study on prognosis of neoadjuvant chemotherapy followed by hepatic surgery versus upfront surgery in patients with synchronous colorectal liver metastasis].
    Wang LJ; Wang HW; Jin KM; Liu W; Bao Q; Wang K; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):248-255. PubMed ID: 34645169
    [No Abstract]   [Full Text] [Related]  

  • 4. Perioperative chemotherapy for resectable colorectal liver metastases: Analysis from the Colorectal Operative Liver Metastases International Collaborative (COLOMIC).
    Gawdi R; Valenzuela CD; Moaven O; Stauffer JA; Del Piccolo NR; Cheung T; Corvera CU; Wisneski AD; Cha C; Russell G; Zarandi N; Dourado J; Shen P
    J Surg Oncol; 2022 Aug; 126(2):339-347. PubMed ID: 35429409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.
    Nordlinger B; Sorbye H; Glimelius B; Poston GJ; Schlag PM; Rougier P; Bechstein WO; Primrose JN; Walpole ET; Finch-Jones M; Jaeck D; Mirza D; Parks RW; Mauer M; Tanis E; Van Cutsem E; Scheithauer W; Gruenberger T; ; ; ; ;
    Lancet Oncol; 2013 Nov; 14(12):1208-15. PubMed ID: 24120480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type of response to conversion chemotherapy strongly impacts survival after hepatectomy for initially unresectable colorectal liver metastases.
    Zimmitti G; Panettieri E; Ardito F; Rosso E; Mele C; Nuzzo G; Giuliante F
    ANZ J Surg; 2020 Apr; 90(4):558-563. PubMed ID: 31927783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of follow-up treatment regimens for colorectal cancer liver metastases without objective response to neoadjuvant chemotherapy: direct surgery or surgery after second-line chemotherapy].
    Lyu XY; Bi XY; Zhao H; Chen QC; Luo ZW; Zhang BL; Zhang XS; Cai JQ
    Zhonghua Wai Ke Za Zhi; 2022 May; 60(5):454-460. PubMed ID: 35359087
    [No Abstract]   [Full Text] [Related]  

  • 8. Neoadjuvant chemotherapy for resectable colorectal liver metastases: what is the evidence? Results of a systematic review of comparative studies.
    Nigri G; Petrucciani N; Ferla F; La Torre M; Aurello P; Ramacciato G
    Surgeon; 2015 Apr; 13(2):83-90. PubMed ID: 25257725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative leukocytosis is an independent risk factor for morbidity and survival after resection of colorectal liver metastases.
    Schnitzler LJ; Oldhafer F; Kulik U; Klempnauer J; Reese T; Oldhafer KJ; Beetz O
    ANZ J Surg; 2022 Oct; 92(10):2551-2559. PubMed ID: 35723493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative second-line chemotherapy is beneficial for resectable liver metastases that occur during or early after adjuvant chemotherapy for colorectal cancer.
    Xu D; Zhu HB; Wang YY; Jin KM; Yan XL; Li J; Wang K; Xing BC
    Int J Colorectal Dis; 2022 Apr; 37(4):805-814. PubMed ID: 35188594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for patients with colorectal liver metastases who underwent curative resection improves long-term outcomes: systematic review and meta-analysis.
    Araujo RL; Gönen M; Herman P
    Ann Surg Oncol; 2015 Sep; 22(9):3070-8. PubMed ID: 25586244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upfront Surgery versus Neoadjuvant Perioperative Chemotherapy for Resectable Colorectal Liver Metastases: A Machine-Learning Decision Tree to Identify the Best Potential Candidates under a Parenchyma-Sparing Policy.
    Famularo S; Milana F; Cimino M; Franchi E; Giuffrida M; Costa G; Procopio F; Donadon M; Torzilli G
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver resection remains a safe procedure after neoadjuvant chemotherapy including bevacizumab: a case-controlled study.
    Tamandl D; Gruenberger B; Klinger M; Herberger B; Kaczirek K; Fleischmann E; Gruenberger T
    Ann Surg; 2010 Jul; 252(1):124-30. PubMed ID: 20562613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy followed by hepatectomy for primarily resectable colorectal cancer liver metastases.
    Chiappa A; Bertani E; Makuuchi M; Zbar AP; Contino G; Viale G; Pruneri G; Bellomi M; Della Vigna P; Zampino MG; Fazio N; Travaini ML; Trifirò G; Corbellini C; Andreoni B
    Hepatogastroenterology; 2009; 56(91-92):829-34. PubMed ID: 19621711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.
    Dupré A; Jones RP; Diaz-Nieto R; Fenwick SW; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2017 Oct; 43(10):1901-1907. PubMed ID: 28888801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Mixed Pathologic Response in Patients with Multiple Colorectal Liver Metastases Treated with Neoadjuvant Chemotherapy and Liver Resection.
    Mason MC; Krasnodebski M; Hester CA; Kothari AN; Barker C; Nishioka Y; Chiang YJ; Newhook TE; Tzeng CD; Chun YS; Vauthey JN; Tran Cao HS
    Ann Surg Oncol; 2022 Aug; 29(8):5156-5164. PubMed ID: 35397746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial of surgery and postoperative modified FOLFOX6 versus surgery and perioperative modified FOLFOX6 plus cetuximab in patients with KRAS wild-type resectable colorectal liver metastases: EXPERT study.
    Matsumura M; Hasegawa K; Oba M; Yamaguchi K; Uetake H; Yoshino T; Morita S; Takahashi K; Unno M; Shimada Y; Muro K; Matsuhashi N; Mori M; Baba H; Shimada M; Mise Y; Kawaguchi Y; Kagimura T; Ishigure K; Saiura A; Sugihara K; Kokudo N
    Langenbecks Arch Surg; 2022 Jun; 407(4):1345-1356. PubMed ID: 35211831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatectomy with Perioperative Chemotherapy for Multiple Colorectal Liver Metastases is the Available Option for Prolonged Survival.
    Omichi K; Inoue Y; Mise Y; Oba A; Ono Y; Sato T; Ito H; Takahashi Y; Saiura A
    Ann Surg Oncol; 2022 Jun; 29(6):3567-3576. PubMed ID: 35118524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival.
    Nanji S; Cleary S; Ryan P; Guindi M; Selvarajah S; Al-Ali H; Grieg P; McGilvary I; Taylor B; Wei A; Moulton CA; Gallinger S
    Ann Surg Oncol; 2013 Jan; 20(1):295-304. PubMed ID: 23054102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.